BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights

  Research and development expenses for the three-month period ended September 30, 2017, were $6.6 million.

  November 28, 2017

   · 

  9 min read
• Genetown

  ReWalk Robotics Announces Full Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares in Follow-on Public Offering

  After the exercise of the option, the total number of ordinary shares sold by ReWalk in the offering increased from 6,857,000 to 7,885,550.

  November 28, 2017

   · 

  5 min read
• Business

  Telcare, a Division of BioTelemetry, Announces Collaboration With Onduo in Diabetes Management Program

  Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.

  November 28, 2017

   · 

  3 min read
• Business

  OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities

  Office of the President continues to perform the duties of President and CEO.

  November 28, 2017

   · 

  3 min read
• Biotech Bay

  Varian Medical Schedules Annual Stockholder Meeting in Palo Alto

  Varian Medical Systems announced today that its Board of Directors has scheduled the 2018 Annual Meeting of Stockholders for February 8, 2018 with a record date of December 11, 2017.

  November 28, 2017

   · 

  1 min read
• Genetown

  Novanta Chairman of the Board Sells a Portion of His Shares for Estate Planning Purposes

  Novanta announced today that the Company’s Chairman of the Board, Stephen W. Bershad, has sold 500,000 common shares, representing approximately 22% of his holdings in the Company.

  November 28, 2017

   · 

  6 min read
• Deals

  CanniMed Therapeutics Acts to Protect Shareholders From Aurora Cannabis’ Opportunistic Offer and Enable Fair Vote on Newstrike Acquisition with Shareholder Rights Plan

  The purpose of the Plan is to ensure that all shareholders are fairly treated, well informed and not subject to coercive bids.

  November 28, 2017

   · 

  8 min read
• Business

  Novoheart Holdings Reports First Quarter 2018 Financial Results

  Novoheart today announced financial results for the three months ended September 30, 2017.

  November 28, 2017

   · 

  17 min read
• Business

  Antibe Therapeutics Reports Q2 2018 Interim Financial and Operating Results and Provides Corporate Update

  The Corporation’s unaudited fiscal Q2 2018 condensed interim consolidated financial statements and MD&A are available on SEDAR.

  November 28, 2017

   · 

  4 min read
• Business

  Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update

  Cash and cash equivalents at September 30, 2017, totaled CHF 20.2 million.

  November 28, 2017

   · 

  10 min read